P1244 FAVORABLE PRECLINICAL PROFILE OF IDX21437, A NOVEL URIDINE NUCLEOTIDE PRODRUG, FOR USE IN A DIRECT-ACTING ANTIVIRAL (DAA) REGIMEN FOR HCV

Autor:	Brenda Hernandez-Santiago, S. Luo, C. Chapron, A. Moussa, S. Bhadresa, Kusum Gupta, X.-R. Pan-Zhou, Benjamin Alexander Mayes, Ilaria Serra, Maria Seifer, M. La Colla, H. Rashidzadeh, R. Rush
Rok vydání:	2014
Předmět:	chemistry.chemical_classification Hepatology business.industry Prodrug Pharmacology Virology Uridine Regimen chemistry.chemical_compound chemistry Medicine Nucleotide business Direct acting
Zdroj:	Journal of Hepatology. 60:S504
ISSN:	0168-8278
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ecb489155664aee852ea788ca3562e5b https://doi.org/10.1016/s0168-8278(14)61404-5 Zobrazit plný text záznamu Full Text from ScienceDirect